Recent evidence has suggested that the rate of uptake of inhalational anaesthetic is constant during maintenance of anaesthesia, contrary to the predictions of multi-compartment uptake models. We measured iso¯urane uptake using a totally closed anaesthetic system during up to 10 h of stable anaesthesia for maxillo-facial surgery on 12 adult patients. Liquid iso¯urane was injected into the system under computer control to produce an end tidal concentration of 1.3 MAC of iso¯urane. Bench tests demonstrated that the leakage from the system was less than 8 ml min ±1 , con®rming that the rate of injection of iso¯urane into the system was a close upper bound on the patients' uptake. Anaesthetic usage for a 70 kg patient was 0.44e ±0.51t + 0.044e ±0.013t +0.058e ±0.00098t ml min ±1 of liquid iso¯urane, where t is duration of anaesthesia in minutes. There was a continuing reduction in anaesthetic requirement even at the end of the period of study that was statistically signi®cant. These data do not support the notion that isourane uptake is constant during stable maintenance of anaesthesia but is compatible with the conventional multi-compartment model of anaesthetic uptake and distribution. 
The uptake of inhalational anaesthetic agents by the body is a subject of both practical and theoretical interest. During induction, an anaesthetizing partial pressure is achieved rapidly at the well-perfused site of action in the brain, but to maintain this partial pressure, anaesthetic must be continuously supplied to meet uptake elsewhere in the body. The total load of anaesthetic is a major factor determining the amount of metabolism and the formation of possibly toxic metabolites. The multi-compartment model of anaesthetic uptake and distribution has been promulgated for many years 1 2 and has much experimental evidence to support it. 2±7 The model represents the human body by a few compartments, each of homogeneous composition and perfusion. Anaesthetic is assumed to accumulate in each compartment at a rate proportional to its perfusion, the partial pressure difference between arterial blood and the compartment, and the solubility of the gas in that compartment. Measurements of the graded manner in which uptake proceeds (i.e. the shape of the uptake curve), provide evidence of the physical factors responsible for the distribution of anaesthetic in the body.
The multi-compartment model has never been accepted universally, 8 and recent work has been interpreted as evidence that anaesthetic uptake is constant after the ®rst few minutes of inhalational anaesthesia. 9 We have investigated this controversy by measuring the uptake of iso¯urane during prolonged anaesthesia. We studied 20 patients undergoing reconstructive head and neck surgery using a computer-controlled closed anaesthetic breathing system into which iso¯urane was injected to maintain a concentration of 1.3 MAC.
Methods

The breathing system
The apparatus used was a functionally closed breathing system, delivering oxygen automatically via a`gas piston'. 10 11 Mechanical ventilation is transmitted from the Y-connector of an Ohmeda 7900 ventilator (Ohmeda, Madison, USA) to the breathing system by a volume of gas acting as a piston in a 6 m`trunk' of 22 mm corrugated plastic tube. There is no conventional fresh gas supply to this system, but some of the oxygen oscillating in the trunk is retained in the circle as oxygen there is consumed by the patient. 12 Liquid iso¯urane is injected directly from a glass syringe (GT-50, SGE Europe Ltd, Milton Keynes, UK) into an in-circle vaporizing chamber (Fig. 1 ). The concentration of iso¯urane within the system is measured by a Capnomac (Datex, Helsinki) multi-gas analyser, which was calibrated before use. The sampled gas is returned to the breathing system. A computer communicates with both this analyser and the iso¯urane syringe pump, and controls the rate of iso¯urane injection to achieve and maintain a predetermined end-expired concentration.
Bench test
Anaesthetic loss from the breathing system was measured using a model lung. 13 The model lung consisted of a 22.2 litre glass bottle with a tracheal tube inserted through its stopper. To prevent any absorption of volatile anaesthetics, the internal surface of the bung was covered with aluminum foil and the exterior of the assembly was covered with a silicone sealant. The model lung was attached to the breathing system in place of a patient. The system was ventilated with a tidal volume of 650 ml at a rate of 10 min ±1 , producing a peak pressure of 25 cm H 2 O. Iso¯urane was injected into the vaporizing chamber as described above, until its concentration in the circuit reached 3%. The injection pump was then stopped and an estimate of the rate of anaesthetic loss from the system was calculated from the wash-out curve. 13 This is the obligatory loss, and is less than we expect to occur clinically.
Conduct of anaesthesia
After Ethics Committee approval and informed consent had been obtained, 20 patients undergoing head and neck surgery, were studied. A multi-disciplinary team of maxillofacial, ENT, and plastic surgeons were involved to undertake these lengthy surgical procedures, some of which lasted up to 18 h. The surgery involved excision of tumour and reconstruction of the defect with a free tissuē ap. The patients received oral temazepam premedication. Anaesthesia was induced with propofol 2.5 mg kg ±1 and fentanyl 4 mg kg ±1 . A laryngeal mask airway (LMA ² ) was then inserted, the patients were connected to a closed breathing system, and controlled ventilation was instituted. Liquid iso¯urane was injected as described above to achieve and maintain an end-expired concentration of 1.5%. The airway was then secured by percutaneous dilatational tracheostomy. Atracurium (0.5 mg kg ±1 ) was used to facilitate insertion of the tracheostomy tube; no further dose of muscle relaxant was administered. The closed breathing system was then disconnected from the laryngeal mask and connected to the cuffed tracheostomy tube. Anaesthesia was continued with 1.5% end-expired iso¯ur-ane and an infusion of fentanyl at 0±5 mg kg ±1 h
±1
. The endexpired carbon dioxide was maintained at 4.5 kPa.
Arterial and central venous catheters were placed using the radial artery and femoral vein respectively. ECG, arterial blood pressure, urine output, temperature (core and peripheral), haemoglobin and haematocrit, arterial blood acid±base status,¯uid intake, and blood loss were monitored throughout. Temperature was maintained by surface warming (Bair Hugger, Eden Prairie, MN, USA). During the ®rst 30 min of anaesthesia, it was occasionally necessary to treat hypotensive episodes with a 3-mg bolus of ephedrine. Thereafter, satisfactory blood pressure was maintained by infusion of i.v.¯uid at 6±8 ml kg ±1 h ±1 , using Hartmann's solution and Gelofusine (Braun, Fig 1 The breathing system. There is no conventional fresh gas¯ow oxygen being drawn up the trunk to replace volume lost from the breathing system from oxygen consumption. The anaesthetist sets the target end-expired iso¯urane concentration on the computer, which then controls the rate of the syringe pump to achieve and maintain that value on the basis of measurements made by the gas analyser. Melsungen, Germany) in a ratio of 4:1. Blood was given as required to maintain the haemoglobin concentration between 8 and 10 g dl ±1 . In closed systems the inspired oxygen fraction (FI O 2 ) reduces as nitrogen accumulates as a result of: (i) wash-out from the patient 14 and (ii) the addition of air from the Capnomac oxygen reference¯ow, which is added to the sample return¯ow at a rate of 24 ml min ±1 . FI O 2 was maintained above 0.3 by intermittently venting the sample returned from the Capnomac so that oxygen entered the system from the gas piston. Any leak in the system revealed itself by an increase in FI O 2 as oxygen from the gas piston replaced volume lost from the system.
Data analysis
The recorded rate of injection was normalized to 70 kg in proportion to each patient's body weight. The patient results were too noisy to allow useful individual analysis. The parameters of the function SA i e ±k i t were adjusted to produce the best (i.e. least squares) simultaneous ®t to the data, using an iterative technique on a spreadsheet (Solver, Microsoft Excel 97 SR-1). This function is the mathematical representation of exponential wash-in to multiple compartments. The signi®cance of improvement in curve ®t with increasing numbers of compartments was assessed using an F-ratio test. 15 If these pharmacokinetic compartments are associated with the classical vessel rich, muscle and fat tissue groups, then compartment volumes and perfusions can be calculated. The amount of iso¯urane in each compartment is given by integrating the appropriate term in the equation from zero to in®nity. At 37°C the vapour volume of iso¯urane is 207 times the liquid volume, and remembering that the equilibrium tissue concentration of iso¯urane is 1.5l TG %, where l TG is the tissue:gas partition coef®cient, we deduce that the volume of the ith compartment is 207 A i / (0.015´k i´lTG ) ml. The compartment perfusion is derived from the rate constant: k i =ql BG /l TG , where l BG is the blood:gas partition coef®cient for iso¯urane and q is the perfusion in units of ml blood (ml tissue) ±1 min ±1 (see Table  2 for the values of partition coef®cient used).
Simple linear regression was used to test the hypothesis that the rate of iso¯urane uptake was continuing to reduce during the terminal period of our study (400±600 min).
Results
Patient characteristics are given in Table 1 . The conduct of anaesthesia was satisfactory in all cases. Temperature was maintained at 37°C (core) and >35°C (peripheral). Urine output was between 2 and 2.5 ml kg ±1 h ±1 . Blood loss was in the range of 1500±2000 ml. Three bench tests were carried out to measure leakage from the system using the arti®cial lung and leakage was found to be 3, 7, and 8 ml min ±1 of liquid iso¯urane.
The records of six patients were discarded from the series because a failure of nitrogen accumulation indicated excessive leak from the system, most probably from the tracheostomy site. Records from two other patients were rejected because the target concentration was changed during the anaesthetic. A full set of the data can be obtained from http.//bja.oupjournals.org. The mean rate of decrease of oxygen concentration among the patients whose results are included in the analysis was 0.12% min ±1 (minimum 0.05% min ±1 ). There was a clear correlation of iso¯urane requirement with patient weight: at 3 h the cumulative uptake correlated signi®cantly with weight (n=11, r 2 =0.76, P<0.0005). Figure 2 shows the rate of iso¯urane injection, normalized for each patient by simple proportion to 70 kg, together with the number of patients contributing data at those times. The data were compatible with a three-compartment model. The line of best ®t is shown in bold in Figure 2 and is given by 0.44e
±0.013t +0.058e ±0.00098t ml min ±1 of liquid iso¯urane for a 70 kg patient, where t is the duration of inhalational anaesthesia in min. The slope of the regression line through the last 200 min of weight-corrected data was signi®cantly different from zero (95% CI from ±0.000075 to ±0.000055 ml min ±2 liquid iso¯urane). The regression line through individual data was also signi®cantly less than zero (P<0.005) for all but one patientÐthe soda lime was changed at 520 min in that case, distorting the data.
When a value of 8 ml min ±1 or less was subtracted from every usage datum point to give an estimate of uptake, the changes were modest: 0.44e
+0.043e
±0.0012t ml min ±1 of liquid iso¯urane for a 70 kg patient. The characteristics of the derived compartments are listed in Table 2 .
Discussion
We have measured the rate of anaesthetic usage and, because the system is closed, we use it as an estimate of the rate of anaesthetic uptake. Our bench tests have shown a loss of up to 8 ml min ±1 from a sealed model lung and we expect that leak around the airway will result in greater Uptake of iso¯urane during prolonged clinical anaesthesia losses in clinical use. There are additional leaks when the airway is manipulated early in the procedure, when the system is¯ushed and during changes of soda lime. We have found no formal data-processing algorithm that allows for these and have rejected the alternative approach of manual adjustment of the data until it`looks right'. We prefer instead to use our data to indicate what must be the upper bounds on actual uptake. The additional losses tend to mask a gradual reduction in anaesthetic requirement. We have been able to demonstrate that a gradual decrease in uptake occurs. Our results are important because of the long duration of the measurements and the fact that we have been generous in the inclusion of losses that work against our signi®cant result. Because these data can be analysed using a variety of methods we have provided access to our original data, so that other workers may inspect or use them. Uptake by the patient does not necessarily imply accumulation within the body. Losses of anaesthetic by diffusion through skin, 16 mucous membrane, from wounds, 17 urine, and metabolism 18 should be insigni®cant. Assuming the solubilities of iso¯urane in urine and saline are the same, the loss is approximately 9 ml of iso¯urane vapour per litre of urine, or 0.5 ml min ±1 liquid iso¯urane for our patients. The iso¯urane content of the blood loss would have been an order of magnitude less. We are aware of only one mechanism by which our results could underestimate uptake. Methane can accumulate in closed breathing systems and has been reported to cause a gas analyser such as ours to read 0.79% halothane spuriously during total i.v. anaesthesia. 19 The gain used in the infra-red system is less when iso¯urane is selected and so methane would cause a lesser reading of 0.13% with iso¯urane. 20 That could mean that we were maintaining only 1.37% iso¯urane (the remainder of the 1.5% being a spurious contribution from methane), resulting in a 9% underestimate of anaesthetic uptake at a true 1.5% concentration.
Airway manipulation and temporary disconnections of the breathing system resulted in very noisy data sets, especially during the ®rst 30 min of anaesthesia. It is surprising that the mean uptake ®gures during this period have such plausible values. These noisy data detract less from the accuracy of our uptake measurements later in the anaesthetic, which was the main focus of this study. Our results show that anaesthetic uptake continues to reduce for 10 h. That may seem to run counter to a recent statement by Hendrickx and co-workers that uptake becomes effectively constant after a 4 min wash-in period. 9 Lin too has claimed that uptake is constant. 8 There are three reasons that make this contradiction more apparent than real. First, we agree with the editorial 21 accompanying Hendrickx's work that his results show uptake reducing throughout the ®rst 49 min, not constant from 4 min. Second, we have presented our results in terms of rate of uptake, not cumulative uptake. The small, continued reduction in rate of uptake would indeed become almost negligible when viewed atop the accumulated load of iso¯urane. Finally, we have been careful to keep our breathing system as near completely closed as possible. A small but constant leak, as might occur in routine use, would require an increase in anaesthetic delivery to counter it, so the reduction in anaesthetic uptake would be a smaller part of the rate of anaesthetic use and therefore less easy to discern. Thus, although we can agree that, for clinical purposes, iso¯urane uptake becomes almost constant after a period of wash-in, uptake actually continues to reduce over a period of at least 10 h. Our results are compatible with the conventional perfusion-limited model of anaesthetic uptake and distribution.
